Duration of Behavioral Counseling Treatment Needed to Optimize Smoking Abstinence
EDC
2 other identifiers
interventional
450
1 country
1
Brief Summary
The purpose of this study is to determine if extending the behavioral smoking-cessation treatment period to one year will significantly improve cessation outcomes among those planning a quit attempt.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4
Started Feb 2008
Longer than P75 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2008
CompletedFirst Submitted
Initial submission to the registry
December 22, 2009
CompletedFirst Posted
Study publicly available on registry
December 24, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2013
CompletedJune 23, 2011
June 1, 2011
4.9 years
December 22, 2009
June 22, 2011
Conditions
Outcome Measures
Primary Outcomes (1)
Proportion of subjects abstinent by treatment group at 1 year post-cessation.
One year
Secondary Outcomes (1)
Proportion of subjects abstinent by treatment group at 2 years post-cessation.
Two years
Study Arms (3)
Brief-Duration Counseling
PLACEBO COMPARATOR3-Month Duration
Moderate Duration Counseling
ACTIVE COMPARATOR6-Month Duration
Extended Duration Counseling
ACTIVE COMPARATOR12-Month Duration
Interventions
Subjects are randomized to one of 3 behavioral treatments: (1) Brief Duration (3 month) smoking-cessation counseling; (2) Moderate Duration (6 month) counseling; or (3) Extended Duration (12 month) counseling
Eligibility Criteria
You may qualify if:
- Daily Cigarette Smokers
You may not qualify if:
- Smokers with active atherosclerotic heart disease, severe cardiac arrhythmias, uncontrolled hypertension, severe peripheral vascular disease, pre-controlled diabetes mellitus, pregnancy, lactation or likely to become pregnant during the study period, and chronic dermatologic disease.
- Smokers who meet DSM-IV lifetime criteria for conditions such as schizo-affective disorder and schizophrenia, bi-polar disorder, or who have had alcohol or drug dependence issues within the past year.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Harvard School of Dental Medicine
Boston, Massachusetts, 02115, United States
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
December 22, 2009
First Posted
December 24, 2009
Study Start
February 1, 2008
Primary Completion
January 1, 2013
Study Completion
January 1, 2013
Last Updated
June 23, 2011
Record last verified: 2011-06